53.5% in 18-44 Age Group Vaccinated Against Covid in India
The ministry of health and family welfare on Sunday said 53.5 per cent of people in the 18-44 age group have been inoculat
Health
News and Articles on Ayurveda, Yoga, Kundalini and other Indian way of health and medicines.
Researchers Devise Method to Tackle COVID-19 PPE Waste
Researchers from the Council of Scientific and Industrial Research (CSIR)’s Pune-based National Chemical Laboratory (CSIR-NCL), Reliance Industries Ltd (RIL), and several other companies from Pune have pooled their expertise to manufacture moulded plastic components from COVID-19 PPE waste.
PM Modi to Launch Nationwide Ayushman Bharat Digital Mission
Based on the foundations laid down in the form of Jan Dhan, Aadhaar and Mobile (JAM) trinity and other digital initiatives of the government, Ayushman Bharat Digital Mission will create a seamless online platform through the provision of a wide-range of data, information and infrastructure services, duly leveraging open, interoperable, standards-based digital systems while ensuring the security, confidentiality and privacy of health-related personal information,” the government said in a statement. The Mission will enable access and exchange of longitudinal health records of citizens with their consent, it said.
Study to Help Develop Better Treatment for Blood-Related Disorders
The new study conducted by researchers at the Indian Institutes of Science Education and Research (IISER) – Mohali, has now filled the gap. It has shown that a local signaling system defined by two genes called Ultrabithorax (Ubx) and Collier in the tertiary lobe regulated the activities of the progenitors in the tertiary as also secondary lobes and that the system shared several biomarkers with the local environment of the primary lobe.
Neighbourhood to Get First Tranche as India Announces Resumption of Covid Vaccine Export
Health minister Mansukh Mandviya said, “In the 4th quarter, after completing our needs, we will produce more. Excess production will help in taking Vaccine Maitri forward. In the 4th quarter under the Vaccine Maitri, we will help the world and fulfill our responsibilities with the COVAX.”
Antiretroviral Therapy Effectively Reduces HIV Deaths: Study
HIV (Human Immunodeficiency Virus) is a virus that attacks the body’s immune system. HIV causes AIDS (Acquired Immune Deficiency Syndrome) and interferes with the body’s ability to fight infections. About HIV AIDS, it is believed that treatment can provide relief, but this condition cannot be cured. The treatment for HIV is called antiretroviral therapy (ART). ART involves taking a combination of HIV medicines (called an HIV treatment regimen) every day.
India Inc Spent Over INR 1,600 Crore on Mitigating Second Covid-19 Wave: Study
In the financial year 2020-21, India Inc. spent over Rs 1,600 crore (US$ 217.02 million) battling the second wave of Covid-19, according to a report released on Monday. According to a research done by CSR information and impact analytics platform ‘CSRBOX’ on over 350 publicly traded businesses, Indian corporations implemented over 750 corporate social responsibility projects in response to the second wave.
CoWIN Launches New API: KYC-VS: Know Your Customer’s/Client’s Vaccination Status
Co-WIN has developed a new API called ‘Know Your Customer’s/Client’s Vaccination Status’ or KYC-VS. To use this API, an individual needs to enter his/her mobile number and name. Thereafter, they will get an OTP which they have to enter. In return, Co-WIN will send a response to the verifying entity on the individual’s status of vaccination
Double Vaccination 97.5% Effective in Preventing Covid Mortality: ICMR
Anti-Covid jabs available in India are around 97% effective in preventing mortality, whereas vaccination also significantly reduces hospitalisation, the assessment of real time vaccination data captured under Covid Vaccine tracker shows.
DCGI Approves Advanced Trials for Biological E. Limited’s COVID- 19 Vaccine
The Drugs Controller General of India (DCGI) has approved Hyderabad-based Biological E. Limited for conducting Phase III comparator safety and immunogenicity trial in adults of its CORBEVAX™ vaccine against COVID-19 after Subject Expert Committee’s (SEC) review of Phase I and II clinical trials data.